A major fire broke out at Syngene International Ltd facility in Biocon Park at Bommasandara-Jigani link road on Monday evening inside the cylinder room and S2 lab block that housed synthetic ...

In a release, Biocon spokesperson said, “The research facility, including office and lab spaces, make up approximately 10 per cent of Syngene’s total infrastructure at Biocon Park.

Biocon plans to set up a new manufacturing facility near its existing campus at an investment of Rs 1,060 crores in Bangalore. The facility is expected to generate at least 750 jobs immediately ...

The State government on Wednesday cleared biotechnology major Biocon Ltd.’s Rs. 1,060-crore investment proposal for setting up a pharmaceutical plant on the outskirts of the city. The proposed ...

Alzumab will be manufactured and formulated as an infusion drug at Biocon’s manufacturing facility at Biocon Park in Bangalore. Psoriasis is a socially debilitating disease affecting 2% to 3 % ...

NEW DELHI: Biotechnology major Biocon on Saturday said it has received approval from the Drugs Controller General of India (DCGI) for use of its biologic drug I ...